Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697)
III期随机研究：高剂量干扰素α-2b治疗T2bNO、T3a-bNO、T4a-bNO和T1-4N1a-2a（显微镜下）黑色素瘤4周：东部肿瘤协作组-美国放射学会影像网络癌症研究组的一项试验（E1697）
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2016.70.2951
Agarwala, Sanjiv S; Lee, Sandra J; Yip, Waiki; Rao, Uma N; Tarhini, Ahmad A; Cohen, Gary I; Reintgen, Douglas S; Evans, Terry L; Brell, Joanna M; Albertini, Mark R; Atkins, Michael B; Dakhil, Shaker R; Conry, Robert M; Sosman, Jeffrey A; Flaherty, Lawrence E; Sondak, Vernon K; Carson, William E; Smylie, Michael G; Pappo, Alberto S; Kefford, Richard F; Kirkwood, John M
